William Earnest Pullman
Director/Board Member at USL Pharma International UK Ltd.
William Earnest Pullman active positions
| Companies | Position | Start | End |
|---|---|---|---|
USL Pharma International UK Ltd.
 USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology USL Pharma International UK Ltd. operates as a holding company whose subsidiaries engages in the development of drugs for the treatment of neurological and inflammatory disorders. The company was founded on June 8, 2012 and is headquartered in London, the United Kingdom. | Director/Board Member | 2013-12-17 | - |
Proximagen Group Plc
 Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2013-12-17 | - |
Career history of William Earnest Pullman
Former positions of William Earnest Pullman
| Companies | Position | Start | End |
|---|---|---|---|
| DYAX CORP. | Chief Tech/Sci/R&D Officer | 2011-06-08 | - |
| Corporate Officer/Principal | 2007-09-30 | 2011-06-08 | |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - | - |
| CUBIST PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 2006-04-30 | - |
Training of William Earnest Pullman
| Australian National University | Doctorate Degree |
| The University of Western Australia | Doctorate Degree |
Statistics
International
| United States | 4 |
| Australia | 3 |
| United Kingdom | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
USL Pharma International UK Ltd.
USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology USL Pharma International UK Ltd. operates as a holding company whose subsidiaries engages in the development of drugs for the treatment of neurological and inflammatory disorders. The company was founded on June 8, 2012 and is headquartered in London, the United Kingdom. | Health Technology |
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
